How I manage cyclic thrombocytopenia

نویسندگان

چکیده

Abstract Cyclic thrombocytopenia (CTP) is a rare disease, which characterized by periodic fluctuation of the platelet count. The pathogenesis CTP unknown and most likely heterogeneous. Patients with are almost always misdiagnosed as having primary immune (ITP). interval between ITP diagnosis can be many years. patients often receive ITP-specific therapies including corticosteroids, thrombopoietin receptor agonists, rituximab, splenectomy, followed transient increase in count that wrongly attributed to treatment effect inevitable “relapse.” diagnosed frequent monitoring, reveals typical pattern cycling. An early will prevent these from being exposed possibly harmful therapies. bleeding phenotype usually mild consists mucocutaneous at time when its nadir. Severe other sites occur but rare. Some respond cyclosporine A or danazol, do not any therapy. associated hematological malignancies disorders thyroid gland. Nevertheless, spontaneous remissions occur, even after

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

How I manage cold agglutinins.

From the Department of Pathology, University of Michigan Medical Center, Ann Arbor, Michigan. Address reprint requests to: W. John Judd, FIBMS, MIBiol, Professor of Immunohematology, Department of Pathology, UH-2G332, University of Michigan Medical Center, 1500 East Medical Center Drive, Ann Arbor, MI 48109-0054; e-mail: [email protected]. Received for publication November 2, 2005; accepted No...

متن کامل

How I manage TFCC injuries

The TFCC consists of triangular fibrocartilage (TFC), meniscus homologue, ulnolunate ligament, ulnotriquetral ligament, radioulnar ligament, and sheath floor of the extensor carpi ulnaris (ECU). The TFCC functions as a stabilizer of the ulnocarpal and DRU joints, load distributor between ulna and ulnar carpus and introduces smooth forearm rotation. The TFCC is a hammock-like shape supporting an...

متن کامل

How I treat How I treat heparin-induced thrombocytopenia

Heparin-induced thrombocytopenia is a prothrombotic adverse drug effect induced by platelet-activating antibodies against multimolecular complexes of platelet factor 4 and heparin. Diagnosis rests on a clinical assessment of disease probability and laboratory testing. Management involves immediate discontinuation of heparin and initiation of an alternative anticoagulant. Because of the frequenc...

متن کامل

How I Treat How I treat thrombocytopenia in pregnancy

A mild thrombocytopenia is relatively frequent during pregnancy and has generally no consequences for either the mother or the fetus. Although representing no threat in the majority of patients, thrombocytopenia may result from a range of pathologic conditions requiring closer monitoring and possible therapy. Two clinical scenarios are particularly relevant for their prevalence and the issues r...

متن کامل

How I diagnose and manage HIT.

Heparin-induced thrombocytopenia (HIT) is a prothrombotic drug reaction caused by platelet-activating IgG antibodies that recognize platelet factor 4 (PF4)/polyanion complexes. Platelet activation assays, such as the serotonin-release assay, are superior to PF4-dependent immunoassays in discerning which heparin-induced antibodies are clinically relevant. When HIT is strongly suspected, standard...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Blood

سال: 2021

ISSN: ['1528-0020', '0006-4971']

DOI: https://doi.org/10.1182/blood.2020008218